Eviogen Discovery is a Contract Research and Innovation partner offering end-to-end drug discovery services—from target identification to lead selection—through flexible FFS or FTE models. With expertise in small/large molecules, PROTACs, biosimilars, and advanced tools like AI-driven discovery, CRISPR editing, and SPR/OCTET affinity studies, we accelerate preclinical to clinical transitions. Our experienced team supports start-ups to global pharma in a cost- and time-efficient manner.
